Clinical trials: To Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days.
- Condition To Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days.
To Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days., To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor.
Multiday Fully Closed Loop Insulin Delivery in Monitored Outpatient Conditions
Insulin replacement therapy is absolutely required for patients with Type 1 diabetes. The insulin pump provides for continuous subcutaneous insulin infusion (CSII), which can approximate the insulin release patterns of the normal…
- Conditions
- To Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days., To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor., To Evaluate the User Experience With a Closed Loop System
- Trial name
- NCT02127827
- Testing
- Automated Ambulatory Glycemic Controller (AAGC)
- Where
- Israel
- Volunteers
- 30 people
- Sponsor
- Sheba Medical Center